Nebulized hypertonic saline in noncystic fibrosis bronchiectasis: a comprehensive review

Therapeutic Advances in Respiratory Disease
Luis Máiz Carro, Miguel A Martínez-García

Abstract

Bronchiectasis occurs as a result of a vicious circle consisting of an impaired mucociliary transport system, inflammation, and infection and repair of the airways. Damage to the mucociliary system prevents secretion elimination and facilitates bacterial growth and bronchial inflammation. To facilitate mucociliary clearance, current guidelines recommend the use of hypertonic saline (HS) solutions in patients with bronchiectasis not secondary to cystic fibrosis (CF), although the evidence of efficacy in this pathology is sparse. A high percentage of patients with CF and bronchiectasis tolerate HS solutions, but often patients report cough, dyspnoea, throat irritation, or salty taste after inhalation. These adverse effects negatively impact adherence to treatment, which sometimes must be discontinued. Some studies have shown that the addition of hyaluronic acid increases the tolerability of HS solutions, both in patients with CF and in bronchiectasis of other etiologies. We aimed to review the benefits and safety of HS solutions in patients with bronchiectasis. The reviews of this paper are available via the supplemental material section.

References

Jul 1, 1994·American Journal of Respiratory and Critical Care Medicine·J A RegnisP T Bye
Jan 1, 1996·American Journal of Respiratory and Critical Care Medicine·P VengeR Dahl
May 1, 1996·Pediatric Pulmonology·L T Rodwell, S D Anderson
Feb 1, 1996·Pediatric Pulmonology·P A EngC F Robertson
Dec 1, 1996·American Journal of Respiratory and Critical Care Medicine·A WannerT G O'Riordan
Nov 26, 1999·American Journal of Respiratory Cell and Molecular Biology·R FortezaG E Conner
Nov 2, 2002·American Journal of Respiratory and Critical Care Medicine·Namita SoodMichael R Knowles
Apr 26, 2003·American Journal of Respiratory and Critical Care Medicine·Gerard M Turino, Jerome O Cantor
Oct 29, 2003·Pulmonary Pharmacology & Therapeutics·Mario Scuri, William M Abraham
Sep 6, 2005·Pulmonary Pharmacology & Therapeutics·L I Z KunzP J Sterk
Jan 20, 2006·The New England Journal of Medicine·Mark R ElkinsUNKNOWN National Hypertonic Saline in Cystic Fibrosis (NHSCF) Study Group
Jan 20, 2006·The New England Journal of Medicine·Scott H DonaldsonRichard C Boucher
Mar 23, 2006·Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine·Evangelia Daviskas, Sandra D Anderson
Sep 1, 2007·American Journal of Respiratory and Critical Care Medicine·Patrick A FlumeUNKNOWN Cystic Fibrosis Foundation, Pulmonary Therapies Committee
Oct 2, 2008·Pediatric Pulmonology·Elisabeth P DellonStephanie D Davis
Nov 15, 2008·Archivos de bronconeumología·Montserrat VendrellAmparo Solé
Jun 23, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Gudmundur BergssonNoel G McElvaney
Jul 22, 2010·Thorax·M C PasteurUNKNOWN British Thoracic Society Bronchiectasis non-CF Guideline Group
Sep 22, 2010·The Medical Journal of Australia·Anne B ChangPaul J Torzillo
Oct 29, 2010·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·David N Sheppard
Feb 19, 2011·American Journal of Respiratory and Critical Care Medicine·Emer P ReevesNoel G McElvaney
Apr 23, 2011·Medicina clínica·Luis Máiz CarroLucrecia Suárez Cortina
Oct 25, 2011·Respiratory Medicine·Fiona Kellett, Niven M Robert
Feb 22, 2012·Respiratory Medicine·Caroline H H NicolsonAnne E Holland
Jul 25, 2012·Pediatric Pulmonology·Manuela GavinaValeria Raia
Oct 22, 2013·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Casilda OlveiraMiguel-Angel Martinez-Garcia
Apr 5, 2014·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Lorenzo DragoRoberto Mattina
May 13, 2014·The Cochrane Database of Systematic Reviews·Anna HartIain Crossingham
Jun 4, 2014·The Journal of Clinical Investigation·Ashley G HendersonMehmet Kesimer
Apr 25, 2015·American Journal of Respiratory and Critical Care Medicine·Wayne H AndersonRichard C Boucher
Apr 26, 2015·Journal of Applied Physiology·W D BennettS H Donaldson
Oct 9, 2015·International Journal of Cell Biology·Mark E LauerMark A Aronica
Jan 10, 2016·American Journal of Physiology. Lung Cellular and Molecular Physiology·Stavros GarantziotisLorenzo Drago

❮ Previous
Next ❯

Citations

Oct 3, 2020·Cells·Luis Máiz Carro, Miguel A Martínez-García
Dec 5, 2020·Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research·Yin ZhangJilei Lin
Sep 15, 2021·Therapeutic Advances in Respiratory Disease·Anna Brooke-HollidgeAdam Lewis

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Cochrane Database of Systematic Reviews
P A B Wark, V McDonald
The Cochrane Database of Systematic Reviews
P A B Wark, V McDonald
© 2021 Meta ULC. All rights reserved